Biotech CEOs - Did I Miss Anyone?

This year was very polar, let's say. There were some resounding successes and resounding failures. I thought your list this year would likely be uncontroversial because there were such object lessons on both sides of how things can go for a biotech company in a 12 month period. It takes more than a CEO to make a success or a failure. Right? So that's kind of the next challenge for ASI. But you know, as you've said in the past, and I think you made a good point, like, you know, getting a drug developed is really just kind of step number one. That doesn't really mean very much if it doesn't end up in the arms